Navigation Links
InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011
Date:12/30/2010

NEW YORK, Dec. 30, 2010 /PRNewswire-FirstCall/ -- InstaCare Corp. (OTC Bulletin Board: ISCR),  the exclusive distributor of the Shasta Genstrip diagnostic testing strips, a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill, as well as leading fulfillment provider of direct to patient diabetes programs, and a developer of revolutionary cell phone centric e-health products and technologies, today announced that the company's Board of Directors will, during the month of January 2011, release Guidance for fiscal year 2011.  On January 10, 2011, a preliminary Guidance release will highlight financial information related to its new at-home diagnostic product, the Shasta Genstrip.  

A more comprehensive Guidance release will be issued on January 24, 2011. A shareholder conference call is also planned following the January 24 Guidance release. The details of the shareholder call, including call-in information, will be made available on our website, www.instacare.net.

Robert Jagunich, Chairman of InstaCare Corp., noted enthusiastically, "These Guidance releases, to be evaluated by an independent financial analyst prior to their release, should communicate the basis of our internal optimism and our confidence in InstaCare's business and revenue models. We believe that our shareholders and the investment community will be impressed with our financial and marketing plan for 2011 and our strategic long term vision. InstaCare will be forecasting, for the first time, the depth and breadth of the financial opportunity that is represented by our new at-home diagnostic testing product, Shasta Genstrip."

For more information about InstaCare Corp. the Shasta Genstrip or its revolutionary MD@Hand cell phone centric technologies, please visit the InstaCare web site www.instacare.net or call the company at (805) 446-2973.

Forward Looking Statements:

Forward looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements.  We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.  Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of December 30, 2010. We anticipate that subsequent events and developments may cause our views to change.


'/>"/>
SOURCE InstaCare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
2. Instacare Corp. Board of Directors Sets Growth Plans for 2010
3. Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
6. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
9. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by ... and just seven days left to go, ALEX is said to be delivered to backers starting May ... ... ... Created by ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... , Feb. 11, 2016 PLAD, Inc. (OTC ... 2016 with sales exceeding company targets, are adding key ... their trademark from the United States Patent and Trademark ... , Chief Executive Officer of PLAD, Inc.  In January, ... Pennsylvania with two new customers, Cumberland ...
Breaking Medicine Technology:
(Date:2/11/2016)... Oregon (PRWEB) , ... February 11, 2016 , ... ... campus participated in the American Osteopathic Association’s (AOA) Match Program Tuesday, February 9, ... Match Program places students into osteopathic graduate medical education positions across the country. ...
(Date:2/11/2016)... ... , ... The Journal of Pain Research has seen a significant ... data taken from the Scopus database (Elsevier B.V.) and is a measure of a ... journal over a three year period and also the importance of the journals where ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... has been gearing up for their simultaneous grand openings in March. All seven ... now that you’re probably wondering, is reversing diabetes possible? According to this 2011 ...
(Date:2/11/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased ... Study for Plans and Purchasers.” Executives from Intel Corp. and Providence Health & ... health benefits program Connected Care, will discuss the challenges they faced (and how ...
(Date:2/11/2016)... ... 2016 , ... PharmMD CEO Robert Yeager announced ... on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include ... data breaches for the Part D Star Rating improvement and Medication Therapy Management ...
Breaking Medicine News(10 mins):